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Abstract
Background: Little is known about the characteristics of patients seeking help from dedicated centers for
undiagnosed and rare diseases. However, information about their demographics, symptoms, prior diagnoses and
medical specialty is crucial to optimize these centers’ processes and infrastructure.
Methods: Using a questionnaire, structured information from 522 adult patients contacting a center for undiagnosed
and rare diseases was obtained. The information included basic sociodemographic data (age, gender, insurance status),
previous hospital admissions, primary symptoms of complaint and previously determined diagnosis.
Results: The majority of patients completing the questionnaire were female, 300 (57 %) vs. 222 men (43 %). The
median age was 52 years (range 18–92). More than half, 309 (59 %), of our patients had never been admitted to a
university hospital. Common diagnoses included other soft tissue disorders, not classified elsewhere (ICD M79, n = 63,
15.3 %), somatoform disorders (ICD F45, n = 51, 12.3 %) and other polyneuropathies (ICD G62, n=36, 8.7 %). The most
frequent symptoms were general weakness (n = 180, 36.6 %) followed by arthralgia (n = 124, 25.2 %) and abdominal
discomfort (n = 113, 23.0 %). The majority of patients had either internal medicine (81.3 %) and/or neurologic (37.6 %)
health problems.
Conclusions: Pain-associated diagnoses and the typical “unexplained” medical conditions (chronic fatigue syndrome,
fibromyalgia, irritable bowel syndrome) are frequent among people contacting a center dedicated to undiagnosed
diseases. The chief symptoms are mostly unspecific. An interdisciplinary organizational approach involving mainly
internal medicine, neurology and psychiatry/psychosomatic care is needed.
Keywords: Rare disease epidemiology, Undiagnosed diseases, Undiagnosed disease program
Background
Determining the correct diagnosis of a rare and undiag-
nosed disease is sometimes troublesome. The diagnostic
possibilities of undiagnosed diseases include the following:
(1) a rare disease, (2) an unusual presentation of a more
common disease, (3) the simultaneous occurrence of
multiple diseases, and (4) an underlying truly new disease.
In particular, ultra-rare diseases are challenging because
standard diagnostic algorithms may not cover these
diseases due to their low prevalence. Often, patients
involve a number of physicians from different specialties
and are admitted multiple times to different hospitals with
little communication between institutions. At some point,
even the most skillful physician begins to question his
clinical reasoning and/or the patient’s reliability. Extensive
diagnostic tests will be repeated, imaging studies
conducted, and altogether, the physician-patient relation-
ship suffers. Moreover, treatment delays and increased
healthcare costs occur as a consequence. However, it is
important to state that rare diseases are not always
undiagnosed, and undiagnosed diseases are not always
rare.
Not every undiagnosed or rare disease presents a chal-
lenge for the general physician. Some diseases present
with pathognomonic, very characteristic symptoms, and
thus an instant diagnosis can be made by simply looking
at the patient, conducting a thorough physical examin-
ation or performing a simple test.
Other diseases present with characteristic combina-
tions of symptoms that are quite common on their own
but are pathognomonic in their unique combination.
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These are the famous triads or tetrads of symptoms
that are laboriously memorized by every medical
student at some point in their education. For example,
Heerfordt’s syndrome, a rare form of sarcoidosis,
presents with a combination of uveitis, facial palsy and
parotitis. Flush, diarrhea and cardiac symptoms point
to endocrine tumors. Iritis, oral and genital aphthous
lesions and erythema nodosum are typical of Behcet’s
disease. For these entities, a diagnosis can be deter-
mined by simply entering the symptoms into a standard
web search engine. For genetic diseases, more special-
ized search engines are available [1].
The geographical aspects of a disease play a critical
role as well. This is especially true for rare infectious
diseases. In western society, common infectious diseases
such as schistosomiasis, Q fever and tuberculosis are
currently quite uncommon. Rocky Mountain spotted
fever and Chagas are only endemic in certain regions.
Consequently, physicians aside from those in tropical
medicine are usually unfamiliar with the symptoms and
diagnosis of these diseases. Furthermore, patients neglect
the health risks of traveling long distances at the last
minute. However, “infectious diseases do not need to
buy plane tickets”; in effect, they travel for free with
infected patients. Accordingly, given the high inter-
national mobility of patients and the rapid same-day
logistics of acquiring goods, even a rural-based western
family physician can encounter almost any infectious or
tropical disease. This is especially true during days of
high migration.
Diseases that present with unspecific, common symp-
toms such as indigestion, nausea, dizziness, joint pain or
headache are difficult to distinguish. The differential
diagnosis of these symptoms is usually broad. On the
one hand, these are quite often symptoms of a general
illness or adverse effects of the patients’ medications. On
the other hand, these symptoms can be signs of serious
diseases as well. This could lead to a cost-intensive test-
ing of a variety of different lab values. Although broad
testing might often be unnecessary and counterproduct-
ive, it is sometimes justified when otherwise frequent
physician and hospital visits could be avoided [2].
The diagnostic heuristics for rare and undiagnosed
diseases are the same. They both require broad interdis-
ciplinary engagement, access to modern information
technology and knowledge resources, and special labora-
tory diagnostic possibilities including molecular genetics
and imaging facilities. Therefore, it is useful to establish
an interdisciplinary center of expertise at a tertiary
university hospital to provide patients and physicians a
central point of care.
The first systematic program for diagnosing rare and
obscure diseases was the Undiagnosed disease program
established by the National Institutes of Health (NIH) in
2008 [3–5]. The NIH Undiagnosed Diseases Program
(UDP), supported by the Office of Rare Diseases Re-
search, the National Human Genome Research Institute
(NHGRI), and the NIH Clinical Center, was established
to diagnose patients who have long sought a diagnosis
and to discover new diseases and insights into their
physiology, cell biology, and biochemistry. As there is a
substantial need for centers for undiagnosed patients,
both from a patient as well as from a physician perspec-
tive, multiple national programs and the Undiagnosed
Diseases Network International (UDNI) were established
[6]. Patients with complex symptoms often consult mul-
tiple, different physicians and are intense users of the
healthcare system. In many cases, after numerous tests
and procedures, this leads to psychiatric or psychosomatic
diagnoses, which are often unsatisfactory. Fibromyalgia is
a typical diagnosis that is often over-diagnosed in chronic
pain patients even if they do not sufficiently fulfill the
diagnostic criteria [7, 8]. However, its distinction from
Dercum’s disease, a rare disease, is sometimes arbitrary,
especially in cases when the patient is obese [7, 9]. Add-
itionally, physicians need a center to refer their patients to
when the cascade of diagnostics and referrals is complete.
In December 2013, a center for undiagnosed and rare
diseases was established at the University Clinic of
Marburg, Germany. The center assists patients and
physicians with diagnostic proposals. The inquiries are
generally patient initiated, and the center is open to the
general public. However, requests from physicians are
preferentially considered. All patients can send their
patient history accompanied by a letter describing the
leading symptoms in their own words to request our
proposal. The service is free of charge. After the file with
the patient’s history is received, it is prepared to be pre-
sented at weekly rounds to experts from all medical fields.
Comparable to the classical tumor board approach, the
case is presented to a board consisting of experienced
senior staff members from different specialties: family
medicine, nephrology, rheumatology, gastroenterology, car-
diology, endocrinology, pneumology, hematology, labora-
tory chemistry, neurology, psychosomatic and radiology.
Each case will then be discussed for approximately 15
to 30 min; in sum, with 10 participating team members,
this leads to a “Physician Brain-Time” of 2.5–5 h. In
daily consultations, this amount can hardly be achieved,
even if the patient is sent to 10 separate specialists.
Furthermore, the intellectual exchange is often more
intense and the differential diagnostic aspects more
diverse than when on an individual basis. Afterwards, a
prospective differential diagnosis and recommendations
for further testing are sent to the patient’s physician
based on the case discussion. For our center, this
system is considered optimal, as it is both practical and
economically feasible to tackle complex cases. In this
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regard, our approach clearly differs from those of the
US UDP and UDNI, as in those programs, applications
are initially evaluated by a multi-specialty board based
on objective signs, symptoms and characteristics that
suggest a reasonable likelihood of obtaining a diagnosis
with current and imminent technologies. Afterwards,
patients are comprehensively evaluated directly at their
respective clinical sites [5]. Most of the cases assessed
at our center appear to be rather common. However,
some of them are also obscure, such as depression
caused by a contraceptive hormone spiral, migraine as
a result of a breast implant, cobalt intoxication from a
defective hip implant [10], partial Sheehan’s syndrome
after complications during birth, allergic alveolitis from
parrots and scurvy caused by an “acid-free” diet. All of
these patients had been undiagnosed for many years.
Often, social factors (job, travel, hobbies) identified by
intensive anamnesis provided the critical clue needed
for the final diagnosis.
However, little is known to date on the characteristics
of the patients seeking help from these dedicated cen-
ters. As this information is crucial for all efforts aiming
to optimize these types of centers (i.e., what experts are
needed and what structure must be provided), we ana-
lyzed the most important characteristics of more than
500 of our patients.
Methods
From December 2013 to July 2014, we sent out 703 ques-
tionnaires to patients (418 female, 285 male) to obtain
structured information on their medical history. The ques-
tionnaire asked for basic sociodemographic data (age, gen-
der, insurance status) as well as the primary symptoms of
their complaint (in free text). In addition, patients were
asked to list the diagnoses that had previously been made.
To assess the use of the healthcare system, the number of
general and university hospital stays in the past three years
was reported on an ordinary scale. A total of 522 (74 %)
questionnaires were returned and are included in this ana-
lysis. The questionnaires were reviewed by three different
readers. These readers looked for key words among the
symptom descriptions, and every symptom of complaint
was coded using an appropriate SNOMED CT term that
provided the closest match. The symptoms were aggre-
gated and subsequently grouped. The diagnoses were
coded using the latest ICD-10 German Modification classi-
fication by an experienced physician. To assess the primary
specialties involved, each patient was assigned a maximum
of three specialties based on their detailed description of
symptoms and previous diagnoses. Already diagnosed rare
diseases were afterwards identified by comparing the coded
ICD diagnosis against a list of diagnoses classified as rare
diseases based on the European definition of a prevalence
lower than 1 per 2000 persons [11].
The datasets were saved in a Microsoft access data-
base, Version 2013. Statistical analyses were performed
using SAS Studio software, university edition, Version
3.4, Cary, North Carolina. Wilcoxon-Mann–Whitney U-
test was used for the comparison analysis (i.e., if gender
or insurance status influenced general healthcare usage)
and to assess the number of extracted symptoms. To test
for gender-related differences in the previously received
diagnoses and reported symptoms, χ2 tests were per-
formed. In all cases, a p value below 0.05 was considered
statistically significant. Prior informed consent was ob-
tained from all patients, and ethical approval of the
study was obtained from the universities’ local ethical
committee.
Results
The majority of patients returning the questionnaire
were female, 300 (57 %) vs. 222 men (43 %). The median
age was 52 years (range 18–92), with the majority of pa-
tients being in their 6th decade (50–59 years); see Fig. 1
for details. Age did not significantly differ between these
two groups. Of all patients, 448 (86 %) were covered by
statutory health insurance, 69 (13 %) were covered by
private insurance and 5 patients (1 %) had an unknown
insurance status. As the proportion of privately insured
patients in the German population is 11 %, privately
insured patients were only marginally overrepresented in
our cohort [12]. The majority of our patients (233, 44 %)
had received one to two stays in a general hospital, and
309 (59 %) had never been admitted to a university
hospital before (see Fig. 2). Healthcare usage as mea-
sured by the number of general or university hospital
stays was not significantly different between men/
women or statutory/private health insured patients (all
p > 0.05). Additionally, 51 % of all patients (53 % female,
47 % male, p = 0.2069) had consulted an alternative prac-
titioner before contacting our center. Most patients had
learned about our center in the media (print media 32.3
%; internet 15.2 %, television 36.9 % and other 15.6 %)
following our publication of a cobalt intoxication due to
an artificial hip transplant in The Lancet [10].
Of all 522 received questionnaires, 413 patients (242
female, 171 male) included information about a prior
diagnosis. The patients listed a median of 3 diagnoses
(range 1–20). Conditions grouped by ICD code M79 –
other soft tissue disorders, not classified elsewhere (in-
cluding fibromyalgia, neuralgia, myalgia and rheumatism)
were significantly more common among female patients.
This group included the single most reported diagnosis of
fibromyalgia (M79.7), reported by 36 (9 %) of our patients.
Fibromyalgia was significantly more frequent in women
(26 female, 7 male, p = 0.0051). As the group was hetero-
geneous, it should be noted that panniculitis (M79.3),
hypertrophy of the infrapatellar fat pad (M79.4), and
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residual foreign body in soft tissue (M79.5) did not occur.
Conditions grouped by ICD code M35—other systemic
involvement of connective tissue, such as sicca syndrome,
overlap syndrome, and polymyalgia rheumatica, were sig-
nificantly more common among women as well. The only
condition that was significantly more frequent among
male patients was sleep apnea syndrome, listed under ICD
code G47. Overall, the high prevalence of pain-related
diagnoses is evident. In total, 51 patients (28 female, 23
male) contacted us with a diagnosis classified as a rare
disease condition. Of these, the largest subgroup repre-
sents 12 patients with known or highly suspected motor
neuron disease (11 amyotrophic lateral sclerosis, 1 bulbar
palsy). Table 1 summarizes the 15 most frequent ICD
diagnoses by category.
Furthermore, 492 patients included a detailed descrip-
tion of their symptoms and ailments in the questionnaire
(286 female, 206 male). The median number of ex-
tracted symptoms was 4 (range 1–25). Female patients
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Fig. 2 Visits to general and university hospitals, grouped by frequency and gender (male: blue; female: red) in the last three years
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significantly more symptoms could be extracted from their
descriptions (p = 0.0175). The most frequent symptom was
a complaint of general weakness and increased fatigue,
followed by arthralgia and abdominal discomfort and pain.
A detailed list of the 20 most common symptoms is pro-
vided in Table 2. Clearly, pain-related symptoms were the
leading complaints of most patients. Based on the symptom
descriptions, the majority of patients were assigned as hav-
ing internal medicine (mostly gastroenterological or rheum-
atological complaints) and neurological health problems
(see Fig. 3 for details).
Discussion
As evidenced by the increasing number of specialized
centers and programs, undiagnosed and rare diseases are
the focus of current developments in the health sector.
This is due to the higher degree of specialization in
almost all fields of medicine, focusing mostly on proced-
ural, well-refunded services rather than poorly funded
diagnostics [13]. Thus far, little is known about the char-
acteristics of the patients contacting such centers. This
study provides detailed insight into this group of
patients. These results are important for optimizing the
structure and procedures of centers dedicated to helping
this suffering group of patients.
The large number of patients seeking some type of sup-
port from centers such as ours underlines the need for
high-end diagnostic institutions. The raw figures of inquir-
ies are comparable with those of the NIH Undiagnosed
Diseases Program; however, nothing compares with the
prestigious NIH, which is of course also true for our lim-
ited personnel and financial resources [4, 5, 14, 15].
Age and gender are the two most significant predis-
posing factors for illness and disease. The majority of
patients were in their sixth decade of life (50–59 years).
The predominance of females among our patients is
again in accordance with the NIH’s figures and could be
due to various reasons. The most obvious reason is that
the adult female population (age 18 years and older) in
Germany outnumbers the male population by approxi-
mately 6 % [16]. Thus, a female dominance in this range
is expected purely by demography. Another factor con-
tributing to this observation might be that women tend
to use ambulatory healthcare services in industrialized
societies more frequently than men do [17], which is
also true for Germany [18–20]. A potential bias might







Rank ICD ICD Caption (n) (%) (n) (%) (n) (%) χ2 p-value
1 M79 Other soft tissue disorders, not elsewhere classified (incl. fibromyalgia,
myalgia, neuralgia, rheumatism)
63 15.3 % 16 9.4 % 47 19.4 % 0.0051
2 F45 Somatoform disorders 51 12.3 % 18 10.5 % 33 13.6 % 0.3440
3 G62 Other polyneuropathies (incl. alcoholic, drug induced, toxic,
unspecified polyneuropathies)
36 8.7 % 17 9.9 % 19 7.9 % 0.4582
4 M54 Dorsalgia 30 7.3 % 9 5.3 % 21 8.7 % 0.1879
5 I10 Essential (primary) hypertension 29 7.0 % 15 8.8 % 14 5.8 % 0.2420
6 F32 Depressive episode 28 6.8 % 11 6.4 % 17 7.0 % 0.8136
M35 Other systemic involvement of connective tissue (incl. sicca syndrome,
overlap syndrome, polymyalgia rheumatica)
28 6.8 % 5 2.9 % 23 9.5 % 0.0088
A69 Other spirochetal infections (incl. Lyme’s disease) 28 6.8 % 16 9.4 % 12 5.0 % 0.0799
7 K58 Irritable bowel syndrome 25 6.1 % 12 7.0 % 13 5.4 % 0.4897
8 T78 Adverse effects, not elsewhere classified (incl. food allergies) 24 5.8 % 8 4.7 % 16 6.6 % 0.4082
9 G93 Other disorders of brain (incl. postviral fatigue syndrome) 21 5.1 % 10 5.8 % 11 4.5 % 0.5529
10 K29 Gastritis and duodenitis 20 4.8 % 5 2.9 % 15 6.2 % 0.1268
11 M19 Other arthrosis 19 4.6 % 6 3.5 % 13 5.4 % 0.3733
12 M47 Spondylosis 18 4.4 % 4 2.3 % 14 5.8 % 0.0911
13 G47 Sleep disorders (incl. sleep apnea) 17 4.1 % 13 7.6 % 4 1.7 % 0.0027
14 E03 Other hypothyroidism 16 3.9 % 7 4.1 % 9 3.7 % 0.8460
G25 Other extrapyramidal and movement disorders (incl. restless legs syndrome) 16 3.9 % 10 5.8 % 6 2.5 % 0.0806
M51 Other intervertebral disc disorders 16 3.9 % 6 3.5 % 10 4.1 % 0.7464
15 E55 Vitamin D deficiency 14 3.4 % 7 4.1 % 7 2.9 % 0.5065
The 15 most frequent ICD diagnosis previously received by our patients grouped by gender and ICD three-letter code. In cases where multiple other diagnoses
are grouped together, the specific diagnostic terms are included
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be the broad media coverage on our center. Because
women are more active in seeking health information,
this might have led to an increase in contacting our
center [21–23].
Interestingly, only 41 % of our patients had been re-
ferred to another university hospital before their initial
contact with our center. In contrast, 51 % of our patients
had consulted an alternative practitioner. This is surpris-
ing and indicates that alternative practitioners are easier
to access than academic centers. This presents an obvious
problem because university hospitals, with their compre-
hensive diagnostic capabilities and their multidisciplinary
structure, are an optimal environment for complex and
challenging cases. This points to a failure in the referral
system and highlights that the regular diagnostic pathway
from general practitioner to specialist to university center
is not functioning properly, which leaves numerous
patients on their own.
The prevalence of pain-associated diagnoses is generally
high among our patients. In particular, unspecified soft
tissue disorders (ICD M79), characterized by pain in the
joints, muscles, nerves, limbs or even the whole body, is
reported by 15 % of our patients. Altogether, the
prevalence of chronic pain conditions is high, the health-
care usage and associated costs are high, and the number
of consulted physicians is high [24–27]. Because our cen-
ter is specialized to rare and/or unexplained diseases, most
patients who were referred to us suffered from medically
“unexplained” conditions (e.g., fibromyalgia, irritable
bowel syndrome, chronic fatigue syndrome) [28, 29]. The
high prevalence of somatoform and affective disorders can
be seen in this context. In addition, numerous patients
with rare diseases contacted our center (n = 51; 12 %).
Among those, patients with known amyotrophic lateral
sclerosis (ALS) comprised the largest subgroup (n = 12, 24
%). Because the diagnosis of ALS had already been made,
these patients did not need our center to achieve a final
diagnosis; however, they clearly hoped for help in con-
fronting this—so far—devastating disease. In contrast, the
fatality of a disease seemed not to be a considerable factor,
as, e.g., only a few patients with progressive neoplasms
contacted us. However, this might be due to the numerous
support systems that exist as “second opinion centers” for
cancer patients.
The majority of health complaints were subjective,
with fatigue, arthralgia and abdominal discomfort listed
Table 2 Top 20 symptoms
Total (n = 492) Men (n = 206) Women (n = 286)
Rank Symptom (n) (%) (n) (%) (n) (%) χ2 p-value
1 Asthenia, general weakness, increased fatigue 180 36.6 % 69 33.5 % 111 38.8 % 0.2271
2 Arthralgia 124 25.2 % 50 24.3 % 74 25.9 % 0.6863
3 Abdominal discomfort and pain 113 23.0 % 37 18.0 % 76 26.6 % 0.0251
4 Headache 91 18.5 % 25 12.1 % 66 23.1 % 0.0020
5 Back pain 84 17.1 % 26 12.6 % 58 20.3 % 0.0259
6 Full body pain 82 16.7 % 31 15.0 % 51 17.8 % 0.4137
7 Dizziness 81 16.5 % 30 14.6 % 51 17.8 % 0.3347
8 Localized pain in a single extremity 79 16.1 % 36 17.5 % 43 15.0 % 0.4669
9 Generalized myalgia 76 15.4 % 30 14.6 % 46 16.1 % 0.6452
10 Gait difficulties 73 14.8 % 33 16.0 % 40 14.0 % 0.5313
11 Paresthesia and dysesthesia 61 12.4 % 23 11.2 % 38 13.3 % 0.4811
12 Muscle cramps and spasms 59 12.0 % 21 10.2 % 38 13.3 % 0.2975
13 Nausea and vomiting 55 11.2 % 12 5.8 % 43 15.0 % 0.0014
14 Palpitations, heart rhythm abnormalities 54 11.0 % 21 10.2 % 33 11.5 % 0.6379
15 Visual disorder, disturbance or defects 53 10.8 % 25 12.1 % 28 9.8 % 0.4077
16 Abnormal stool consistency and frequencies 51 10.4 % 17 8.3 % 34 11.9 % 0.1918
17 Dyspnea 43 8.7 % 16 7.8 % 27 9.4 % 0.5167
18 Dyssomnia 39 7.9 % 16 7.8 % 23 8.0 % 0.9113
Sensation of abnormal heat or cold 39 7.9 % 18 8.7 % 21 7.3 % 0.5720
19 Edema 37 7.5 % 8 3.9 % 29 10.1 % 0.0094
20 Hyperhidrosis 34 6.9 % 14 6.8 % 20 7.0 % 0.9323
Exanthema, erythema 34 6.9 % 13 6.3 % 21 7.3 % 0.6561
Absolute and percentage of the 20 most frequent symptoms grouped by gender
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as the three most common symptoms. The high preva-
lence of unspecific health complaints especially in the
musculoskeletal, neurological and gastrointestinal system
has been identified in broad population studies from
health insurance and healthcare providers [30, 31]. Com-
parable to our observation of a median of 4 reported
symptoms, these studies report a median number of
symptoms ranging from 4–8. However, the methodology
in these studies differed from our own. Instead of select-
ing symptoms from a predefined list of symptoms, we
used an open-ended free-text approach comparable to
an initial question in a traditional anamnesis.
Most of our patients had conditions in the area of
internal medicine. Internal medicine can further be
divided into subspecialties, and neurology was the most
prominent single category. Due to the high comorbidity
with suspected psychosomatic disorders, this specialty is
similarly over-represented. Interestingly, our patient
characteristics are comparable with those reported by
Gahl et al. for the NIH UDP [15], with large numbers of
neurological and gastrointestinal cases. Nevertheless, as
our evaluation process differs from theirs and the vast
majority of our cases are self-referrals, these statistics
are difficult to compare. These data are important for
the structure and composition of interdisciplinary teams
in centers dedicated to undiagnosed and rare diseases in
adults. In this cohort, neurological and gastrointestinal
cases were prominent as well. The assignment of these
complex cases to a single specialty is not possible, as
they often have multiple diagnoses and symptoms
involving various organ systems and disciplines. There-
fore, not only a multidisciplinary but a true interdiscip-
linary approach is essential.
The main limitation of our study was the reliance on
self-reported data for all the variables of investigation.
The accuracy of self-reported healthcare usage is
strongly influenced by the timeframe and actual
frequency. A longer timeframe could lead to underesti-
mation [32]. As we used an open-end free-text approach
to study the main symptoms, factors such as education,
clinical experience and other factors might bias the
































































































































































Fig. 3 Classification of case presentations by specialty (a); as the largest number was assigned to internal medicine, this group was further divided by
subspecialty (b)
Mueller et al. Orphanet Journal of Rare Diseases  (2016) 11:81 Page 7 of 9
genetic diseases that have onsets in childhood are unrep-
resented. At this point in time we are unable to report a
success rate of our approach, which is the topic of a
follow up study.
Our initial data demonstrate a substantial need in our
healthcare system for dedicated centers for patients
with unclear and undiagnosed diseases. For these
patients (and for us), it is unimportant whether their
request is objectively, medically justified—these patients
suffer and feel undiagnosed. Usually multiple physicians
had been previously involved, a previous diagnosis of
one of the classical “unexplained” medical conditions
established, and the number of “unspecific” symptoms
high. These patients search for an underlying somatic
explanation. With increasing research, there is rising
evidence that a number of rare conditions can mimic
these “unexplained” conditions. For instance, the
improved understanding of rare hereditary sodium
channelopathies suggests that these may play a vital
role in the diagnosis and treatment of some painful
neuropathies [33, 34] and that in some cases, the initial
diagnosis of fibromyalgia was misleading [35]. Other
rare conditions prone to delayed diagnosis are adrenal
insufficiency, hereditary angioedema and cerebrotendi-
nous xanthomatosis [35–38]. A new cornerstone could
be the identification of novel possibilities along with
the broad availability of next-generation-sequencing
(NGS). The initial results lead to promising insights
[39, 40]. The increasing use of clinical decision support
systems and dedicated software systems will improve
our approach regarding undiagnosed diseases [41].
Conclusion
There is a high demand by adult patients who feel undiag-
nosed and who are seeking a second opinion in a special-
ized center. Therefore, dedicated centers for undiagnosed
and rare diseases are needed. The majority of patients
were middle-aged, with a slight female predominance.
Pain-related diagnoses and conditions were frequent,
along with diagnoses including the typical “unexplained”
medical conditions (chronic fatigue syndrome, fibromyal-
gia, irritable bowel syndrome). The chief symptoms were
unspecific in general. An interdisciplinary organizational
approach involving mainly internal medicine, neurology
and psychiatry/psychosomatic is needed.
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